Apimeds Pharmaceuticals US, Inc. stock forecast
Want to see APUS full AI Analyst Report?
Apimeds Pharmaceuticals US, Inc. (APUS) Stock Forecast & Price Target
APUS Analyst Ratings
APUS Stock 12 Month Forecast
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | $2→$1.50 | sell | -6.25%Downside | Reiterated | 11/20/26 | ||
| Google Biotechnology | TipRanks - Google | $2→$1.50 | hold | -6.25%Downside | Reiterated | 11/20/26 | ||
| Anthropic Biotechnology | TipRanks - Anthropic | $2→$1.50 | hold | -6.25%Downside | Reiterated | 11/20/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | $2→$1.50 | hold | -6.25%Downside | Reiterated | 11/20/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | $2→$1.50 | hold | -6.25%Downside | Upgraded | 11/20/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | $2→$1.50 | hold | -6.25%Downside | Reiterated | 11/20/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| PerPlexity - SonarReasoningProTipRanks - PerPlexity | SellReiterated$2→$1.50 | 11/20/26 | -6.25%Downside | ||
| Google BiotechnologyTipRanks - Google | HoldReiterated$2→$1.50 | 11/20/26 | -6.25%Downside | ||
| Anthropic BiotechnologyTipRanks - Anthropic | HoldReiterated$2→$1.50 | 11/20/26 | -6.25%Downside | ||
| OpenAI - Gpt-5.6SolTipRanks - OpenAI | HoldReiterated$2→$1.50 | 11/20/26 | -6.25%Downside | ||
| DeepSeek - V4ProTipRanks - DeepSeek | HoldUpgraded$2→$1.50 | 11/20/26 | -6.25%Downside | ||
| xAI - Grok-4.3TipRanks - xAI | HoldReiterated$2→$1.50 | 11/20/26 | -6.25%Downside |
Best Analysts Covering Apimeds Pharmaceuticals US, Inc.
Copying PerPlexity Biotechnology's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
Copying PerPlexity Biotechnology's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
Copying PerPlexity Biotechnology's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
APUS Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, APUS has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. APUS average Analyst price target in the past 3 months is ―.
